535
edits
Changes
no edit summary
[[File:sandboxJointventure.jpgPNG|200px|thumb|right|Logo of Team SanboxJoint Venture]]
==Molecular Recognition ==
Our point-of-care system makes use of a magnetic microparticle centrifugation technique coupled with the char-acteristic characteristic bright red colour of AuNPs1 2to AuNPs to give an optical readout proportional to the concentration of ADL in thepatient’s plasma.
== Physical Transduction ==
== Cartridge ==
In order to minimise our environmental impact, oursensor our sensor has been designed to rely on modified clearacrylic slides, as can be seen in Appendix II. Theseare Thes eare easily produced at low cost with a minimal envi-ronmental impact caused by mass development.
== Reader Instrument ==
Our biosensor’s screen is the main communication point for the patient, with our appADAacting app ADA acting as a tool touse to use alongside for tracking and management. There is a large, easy to use touch screen, housed in a sensor 20 by 14 by 10 cm in size.
